BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Arvinas

Arvinas logo

Founded
2013
Patents
26
Clinical Trials
2
Publications
42

Technologies

Protein Degraders Startups

Arvinas is a pharmaceutical company focused on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Central to Arvinas’ proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body. This strategy of degradation versus protein inhibition holds several advantages including the potential to target proteins that are not currently ‘druggable’ using a small molecule approach.

Become a Member to view additional information about this company

Posts Mentioning This Company